COVID-19 infection among patients on dialysis was 20-fold greater: NephroPlus study biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
COVID-19 Booster Shots and HIV: What to Know Right Now thebody.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thebody.com Daily Mail and Mail on Sunday newspapers.
Diagnosis, Education, and Care of Patients with APOL1-Associated Nephropathy: A Delphi Consensus and Systematic Review asnjournals.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asnjournals.org Daily Mail and Mail on Sunday newspapers.
Roxadustat Promise for Oral Treatment of Anemia in Kidney Disease medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Procurement Biopsy Data Quality Limits Comparability of United States and French Deceased Donor Kidney Biopsies asnjournals.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asnjournals.org Daily Mail and Mail on Sunday newspapers.
E-Mail IMAGE: Genetic background and clinical features of adult patients suspected with nephronophthisis on renal biopsy view more Credit: Department of Nephrology,TMDU Researchers at Tokyo Medical and Dental University (TMDU) in a pioneering study identify clinical, genetic and histopathological characteristics that may help confirm the diagnosis when nephronophthisis occurs in adults Tokyo, Japan - Nephronophthisis (NPH) is a kidney disease affecting mainly children. Now, for the first time, researchers at Tokyo Medical and Dental University (TMDU) have studied a number of adults with NPH and highlighted clinical, genetic and pathological characteristics that could help in confirming this challenging diagnosis.
Awareness drive on vaccination for dialysis patients Updated: Updated: Share Article AAA NephroPlus, the dialysis care network, is organising a national education drive on COVID vaccination for dialysis patients across their centres. The aim of the initiative is to dispel certain myths associated with taking the vaccine and encourage them by addressing their concerns on the safety and efficacy of vaccine. Dialysis patients are at a very high risk of getting COVID-hit, as they have very low immunity compared to healthy individuals. The international journal, ‘Kidney International Reports’, had said that COVID-19 prevalence among dialysis patients is about 20 times higher than healthy population.
ROCHESTER, Minn. A study by Mayo Clinic researchers published in Kidney International Reports finds that immune checkpoint inhibitors, may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis. Immune checkpoint inhibitors are used to treat cancer by stimulating the immune system to attack cancerous cells. Immune checkpoint inhibitors have improved the prognosis for patients with a wide range of malignancies including melanoma, non-small cell lung cancer and renal cancer, says Sandra Herrmann, M.D., a Mayo Clinic nephrologist and the study s senior author. In some patients, this enhanced immune response may target kidney tissue, leading to acute kidney inflammation known as interstitial nephritis.
Biomarkers could help discriminate cancer therapy-associated kidney injury from other causes A study by Mayo Clinic researchers published in Kidney International Reports finds that immune checkpoint inhibitors, may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis. Immune checkpoint inhibitors are used to treat cancer by stimulating the immune system to attack cancerous cells. Immune checkpoint inhibitors have improved the prognosis for patients with a wide range of malignancies including melanoma, non-small cell lung cancer and renal cancer. In some patients, this enhanced immune response may target kidney tissue, leading to acute kidney inflammation known as interstitial nephritis.
Date Time Study examines role of biomarkers to evaluate kidney injury in cancer patients undergoing immunotherapy A study by Mayo Clinic researchers published in Kidney International Reports finds that immune checkpoint inhibitors, may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis. Immune checkpoint inhibitors are used to treat cancer by stimulating the immune system to attack cancerous cells. “Immune checkpoint inhibitors have improved the prognosis for patients with a wide range of malignancies including melanoma, non-small cell lung cancer and renal cancer,” says Sandra Herrmann, M.D., a Mayo Clinic nephrologist and the study’s senior author. “In some patients, this enhanced immune response may target kidney tissue, leading to acute kidney inflammation known as interstitial nephritis.”